Collectively, our findings convincingly demonstrate that the NASH-prone phenotypes are recapitulated by employing human Nrf1α−/−-driven cells, in which Nrf2 may also be critical for this pathogenesis. Here, NFE2L2 is linked to metabolic dysfunction-associated steatohepatitis.